More than just an expert network, Dexter is a curated community of people passionate about facilitating scientific collaboration.
Whether you're a decision-maker at a precision medicine company or an expert looking to share your knowledge to advance innovation, Dexter's here to make your collaborations as streamlined and advantageous as they can be.
We are a community.
We are disruptors. We are facilitators.
We make the magic happen.
And - most importantly - we are all in this together.
We are Dexter.
At Dexter, our vision is only outmatched by our ideals. Along with bridging the gap between industry and research, we believe in providing a simplified, streamlined experience to encourage as many relevant connections as possible.
After all, the more meaningful connections companies can make with KOLs & end users, the greater the collaboration and scientific innovation. The greater the innovation, the more we help accelerate the development of real-world solutions through precision medicine.
And the more solutions we develop, the more we can change the world.
We're always interested in improving the platform and expanding our community - let us know if you have any questions or comments.
Since its inception in 2018, Dexter has made many strides in becoming the most streamlined, user-friendly expert network, thanks in part to the amazing life science professionals that make up our community.
Join us as we continue on our journey!
We are seeking survey responses from customers in the biopharma and cellular delivery space to gain insights on optimal cellular therapy applications and their associated market opportunity
We are looking for experts to provide insights on the Women's Health space for an advisory board
Our client is looking to engage experts with insights on the clonal fragment market size and related trends
We are looking to understand molecular diagnostics testing practices in European hospital labs in relation to COVID-19
We are looking to engage experts with insights on the global oncology biomarker testing landscape
We are looking to have an in-depth discussion with knowledgeable individuals about the NGS manufacturers market
We are seeking Biopharma experts with an understanding of the clinical-genomic landscape & trends
We are looking to get feedback from experts in the biopharma and AMC spaces on MRD assays
We are seeking individuals with knowledge and experience of bioconjugation/polymer synthesis and service providers in the field
We are looking for clinical research and care professionals who are pathologists or lab directors that have experience with digital pathology
We are looking to conduct a survey to understand the use of and interest in point-of-care tests and point-of-care testing platforms, specifically focusing on at-home, PCR-based tests
We are looking for experts in digital pathology who have perspectives on the current market landscape
Our client is looking to engage experts to gain insights into a benchtop custom oligo synthesis technology
We are conducting internal research to understand the current liquid biopsy minimal residual disease (MRD) and monitoring test utilization, as well as the overall market landscape
We are in the process of building a process, clinical, and economic value map for pathology for oncology.
We are running a 2-min survey to identify entertaining correlations among NGS users.
Our client is looking to engage experts with insights on Liquid Biopsy Panel Pricing.
Our client is looking to engage experts with insights on utilization and/ or purchase of RWD (real-world data).
We are interviewing biopharma stakeholders to gain a better understanding for the current landscape and future trends for CDx Development.
We are currently conducting a research study to understand current and future trends regarding the utilization of liquid biopsy assays.